{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T22:32:53Z","timestamp":1783722773385,"version":"3.55.0"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100015796","name":"Shanghai Lingjun Program","doi-asserted-by":"publisher","award":["23YF1441800"],"award-info":[{"award-number":["23YF1441800"]}],"id":[{"id":"10.13039\/100015796","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007219","name":"Natural Science Foundation of Shanghai Municipality","doi-asserted-by":"publisher","award":["21ZR1459700"],"award-info":[{"award-number":["21ZR1459700"]}],"id":[{"id":"10.13039\/100007219","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2023 M730722"],"award-info":[{"award-number":["2023 M730722"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003347","name":"Fudan University","doi-asserted-by":"publisher","award":["2024ZYYS-016"],"award-info":[{"award-number":["2024ZYYS-016"]}],"id":[{"id":"10.13039\/501100003347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82371920"],"award-info":[{"award-number":["82371920"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejradiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Radiology"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.ejrad.2025.112267","type":"journal-article","created":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T19:54:13Z","timestamp":1750967653000},"page":"112267","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Performance of conventional MRI and endoscopy in assessing complete tumor response following immunotherapy-based neoadjuvant therapy for rectal cancer"],"prefix":"10.1016","volume":"190","author":[{"given":"Gengyun","family":"Miao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wentao","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lechi","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lamei","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianyong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengjiang","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiyuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaohua","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingli","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoxiang","family":"Xuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoxiang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengxiang","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengsu","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.ejrad.2025.112267_b0005","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.6004\/jnccn.2022.7061","article-title":"Optimal neoadjuvant strategies for locally advanced rectal cancer by risk assessment and tumor location","volume":"20","author":"Saraf","year":"2022","journal-title":"J. Natl. Compr. Canc. Netw."},{"issue":"23","key":"10.1016\/j.ejrad.2025.112267_b0010","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1200\/JCO.22.00032","article-title":"Organ Preservation in patients with Rectal Adenocarcinoma Treated with Total Neoadjuvant Therapy","volume":"40","author":"Garcia-Aguilar","year":"2022","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ejrad.2025.112267_b0015","doi-asserted-by":"crossref","unstructured":"A.B. Benson, A.P. Venook, M.M. Al-Hawary, N. Azad, Y.-J. Chen, K.K. Ciombor, S. Cohen, H.S. Cooper, D. Deming, I. Garrido-Laguna, J.L. Grem, A. Gunn, J.R. Hecht, S. Hoffe, J. Hubbard, S. Hunt, W. Jeck, K.L. Johung, N. Kirilcuk, S. Krishnamurthi, J.K. Maratt, W.A. Messersmith, J. Meyerhardt, E.D. Miller, M.F. Mulcahy, S. Nurkin, M.J. Overman, A. Parikh, H. Patel, K. Pedersen, L. Saltz, C. Schneider, D. Shibata, J.M. Skibber, C.T. Sofocleous, E. Stotsky-Himelfarb, A. Tavakkoli, C.G. Willett, K. Gregory, L. Gurski, Rectal Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology, J Natl Compr Canc Netw 20(10) (2022) 1139-1167.","DOI":"10.6004\/jnccn.2022.0051"},{"issue":"5","key":"10.1016\/j.ejrad.2025.112267_b0020","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1158\/1078-0432.CCR-20-3445","article-title":"Gut Microbiome Components Predict Response to Neoadjuvant Chemoradiotherapy in patients with locally Advanced Rectal Cancer: a prospective","volume":"27","author":"Yi","year":"2021","journal-title":"Longitudinal Study, Clin Cancer Res"},{"key":"10.1016\/j.ejrad.2025.112267_b0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.103945","article-title":"Response prediction and risk stratification of patients with rectal cancer after neoadjuvant therapy through an analysis of circulating tumour DNA","volume":"78","author":"Liu","year":"2022","journal-title":"EBioMedicine"},{"issue":"28","key":"10.1016\/j.ejrad.2025.112267_b0030","doi-asserted-by":"crossref","first-page":"3308","DOI":"10.1200\/JCO.23.02261","article-title":"Randomized phase II Trial of Immunotherapy-based Total Neoadjuvant Therapy for Proficient Mismatch Repair or Microsatellite Stable locally Advanced Rectal Cancer (TORCH)","volume":"42","author":"Xia","year":"2024","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.ejrad.2025.112267_b0035","doi-asserted-by":"crossref","DOI":"10.6004\/jnccn.2022.7071","article-title":"Prevalent Pseudoprogression and Pseudoresidue in patients with Rectal Cancer Treated with Neoadjuvant Immune Checkpoint Inhibitors","volume":"21","author":"Xie","year":"2023","journal-title":"J. Natl. Compr. Canc. Netw."},{"issue":"1","key":"10.1016\/j.ejrad.2025.112267_b0040","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.221529","article-title":"Watch-and-wait Approach to Rectal Cancer: the Role of Imaging","volume":"307","author":"Jayaprakasam","year":"2023","journal-title":"Radiology"},{"issue":"4","key":"10.1016\/j.ejrad.2025.112267_b0045","doi-asserted-by":"crossref","DOI":"10.1148\/rg.220135","article-title":"Restaging MRI of Rectal Adenocarcinoma after Neoadjuvant Chemoradiotherapy: Imaging Findings and potential pitfalls","volume":"43","author":"Awiwi","year":"2023","journal-title":"Radiographics"},{"issue":"5","key":"10.1016\/j.ejrad.2025.112267_b0050","doi-asserted-by":"crossref","first-page":"e780","DOI":"10.1002\/onco.13707","article-title":"College of American Pathologists Tumor Regression Grading System for Long-Term Outcome in patients with locally Advanced Rectal Cancer","volume":"26","author":"Chen","year":"2021","journal-title":"Oncologist"},{"issue":"4","key":"10.1016\/j.ejrad.2025.112267_b0055","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1245\/s10434-017-6025-x","article-title":"8th Edition of the AJCC Cancer Staging Manual: Pancreas and Hepatobiliary Cancers","volume":"25","author":"Chun","year":"2018","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.ejrad.2025.112267_b0060","series-title":"Applied logistic regression, third edition","author":"Hosmer","year":"2013"},{"issue":"4","key":"10.1016\/j.ejrad.2025.112267_b0065","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoncol.2018.5896","article-title":"Assessment of a Watch-and-wait strategy for Rectal Cancer in patients with a complete Response after Neoadjuvant Therapy","volume":"5","author":"Smith","year":"2019","journal-title":"JAMA Oncol."},{"issue":"12","key":"10.1016\/j.ejrad.2025.112267_b0070","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/s41571-021-00538-5","article-title":"International consensus recommendations on key outcome measures for organ preservation after (chemo)radiotherapy in patients with rectal cancer","volume":"18","author":"Fokas","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.ejrad.2025.112267_b0075","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1158\/1078-0432.CCR-21-3213","article-title":"Preoperative Chemoradiotherapy plus Nivolumab before Surgery in patients with Microsatellite Stable and Microsatellite Instability-High locally Advanced Rectal Cancer","volume":"28","author":"Bando","year":"2022","journal-title":"Clin. Cancer Res."},{"issue":"11","key":"10.1016\/j.ejrad.2025.112267_b0080","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-003554","article-title":"Phase II, single-arm trial of preoperative short-course radiotherapy followed by chemotherapy and camrelizumab in locally advanced rectal cancer","volume":"9","author":"Lin","year":"2021","journal-title":"J. Immunother. Cancer"},{"issue":"4_suppl","key":"10.1016\/j.ejrad.2025.112267_b0085","first-page":"99","article-title":"Phase II study of durvalumab following neoadjuvant chemoRT in operable rectal cancer","volume":"40","author":"George","year":"2022","journal-title":"NSABP FR-2"},{"issue":"17_suppl","key":"10.1016\/j.ejrad.2025.112267_b0090","volume":"40","author":"Tamberi","year":"2022","journal-title":"A Phase II Study of Capecitabine plus Concomitant Radiation Therapy Followed by Durvalumab (MEDI4736) as Preoperative Treatment in Rectal Cancer: PANDORA Study Final Results"},{"issue":"15_suppl","key":"10.1016\/j.ejrad.2025.112267_b0095","first-page":"3511","article-title":"Phase II study of preoperative (PREOP) chemoradiotherapy (CTRT) plus avelumab (AVE) in patients (PTS) with locally advanced rectal cancer (LARC)","volume":"39","author":"Salvatore","year":"2021","journal-title":"The AVANA Study"},{"issue":"6","key":"10.1016\/j.ejrad.2025.112267_b0100","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1093\/annonc\/mdy183","article-title":"Peri-operative therapy for operable gastroesophageal adenocarcinoma: past, present and future","volume":"29","author":"Aggelis","year":"2018","journal-title":"Ann. Oncol."},{"issue":"1","key":"10.1016\/j.ejrad.2025.112267_b0105","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/s41392-024-01762-y","article-title":"Efficacy and safety of PD-1 blockade plus long-course chemoradiotherapy in locally advanced rectal cancer (NECTAR): a multi-center phase 2 study","volume":"9","author":"Yang","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"issue":"16_suppl","key":"10.1016\/j.ejrad.2025.112267_b0110","first-page":"e15603","volume":"40","author":"Zhou","year":"2022","journal-title":"The Clinical Efficacy and Safety of Neoadjuvant Chemoradiation Therapy with Immunotherapy for the Organ Preservation of Ultra Low Rectal Cancer: A Single Arm and Open Label Exploratory Study"},{"issue":"16_suppl","key":"10.1016\/j.ejrad.2025.112267_b0115","first-page":"3609","volume":"40","author":"Wu","year":"2022","journal-title":"04 Trial: Total Neoadjuvant Chemoradiation Combined with Neoadjuvant PD-1 Blockade for pMMR\/MSS Locally Advanced Middle to Low Rectal Cancer"},{"key":"10.1016\/j.ejrad.2025.112267_b0120","doi-asserted-by":"crossref","first-page":"S430","DOI":"10.1016\/j.annonc.2023.09.1786","article-title":"595P the DUREC trial: Durvalumab plus total neoadjuvant therapy in locally advanced rectal cancer - a multicenter, single-arm, phase II study (GEMCAD-1703)","volume":"34","author":"Capdevila Castillon","year":"2023","journal-title":"Ann. Oncol."},{"issue":"1","key":"10.1016\/j.ejrad.2025.112267_b0125","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1186\/s13014-020-01673-6","article-title":"Efficacy and safety-in analysis of short-course radiation followed by mFOLFOX-6 plus avelumab for locally advanced rectal adenocarcinoma","volume":"15","author":"Shamseddine","year":"2020","journal-title":"Radiat. Oncol."},{"issue":"6","key":"10.1016\/j.ejrad.2025.112267_b0130","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/s41575-024-00900-9","article-title":"Future direction of total neoadjuvant therapy for locally advanced rectal cancer","volume":"21","author":"Kagawa","year":"2024","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"12","key":"10.1016\/j.ejrad.2025.112267_b0135","doi-asserted-by":"crossref","first-page":"7516","DOI":"10.4049\/jimmunol.174.12.7516","article-title":"Local radiation therapy of B16 melanoma tumors increases the generation of tumor antigen-specific effector cells that traffic to the tumor","volume":"174","author":"Lugade","year":"2005","journal-title":"J. Immunol."},{"issue":"7547","key":"10.1016\/j.ejrad.2025.112267_b0140","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/nature14292","article-title":"Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer","volume":"520","author":"Twyman-Saint Victor","year":"2015","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.ejrad.2025.112267_b0145","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1172\/JCI67313","article-title":"Irradiation and anti-PD-L1 treatment synergistically promote antitumor immunity in mice","volume":"124","author":"Deng","year":"2014","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejrad.2025.112267_b0150","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s40425-016-0149-6","article-title":"A hypofractionated radiation regimen avoids the lymphopenia associated with neoadjuvant chemoradiation therapy of borderline resectable and locally advanced pancreatic adenocarcinoma","volume":"4","author":"Crocenzi","year":"2016","journal-title":"J. Immunother. Cancer"},{"issue":"10","key":"10.1016\/j.ejrad.2025.112267_b0155","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.6004\/jnccn.2015.0151","article-title":"Survival in patients with Severe Lymphopenia following Treatment with Radiation and Chemotherapy for newly Diagnosed Solid Tumors","volume":"13","author":"Grossman","year":"2015","journal-title":"J. Natl. Compr. Canc. Netw."},{"issue":"1","key":"10.1016\/j.ejrad.2025.112267_b0160","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ijrobp.2019.02.046","article-title":"Immunomodulatory Effects of Stereotactic Body Radiation Therapy: Preclinical Insights and Clinical Opportunities","volume":"110","author":"Marciscano","year":"2021","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"4","key":"10.1016\/j.ejrad.2025.112267_b0165","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/j.ijrobp.2006.07.1362","article-title":"Effects of radiotherapy and chemotherapy on angiogenesis and leukocyte infiltration in rectal cancer","volume":"66","author":"Baeten","year":"2006","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"3","key":"10.1016\/j.ejrad.2025.112267_b0170","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1093\/annonc\/mdz003","article-title":"Novel patterns of response under immunotherapy","volume":"30","author":"Borcoman","year":"2019","journal-title":"Ann. Oncol."},{"issue":"1","key":"10.1016\/j.ejrad.2025.112267_b0175","article-title":"Development and validation of a radiopathomics model to predict pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a multicentre observational study","volume":"4","author":"Feng","year":"2022","journal-title":"Lancet Digit Health"},{"issue":"3","key":"10.1016\/j.ejrad.2025.112267_b0180","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1007\/s00330-022-09191-7","article-title":"Quantitative synthetic MRI for predicting locally advanced rectal cancer response to neoadjuvant chemoradiotherapy","volume":"33","author":"Lian","year":"2023","journal-title":"Eur. Radiol."},{"issue":"3","key":"10.1016\/j.ejrad.2025.112267_b0185","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/s41591-020-01224-2","article-title":"Neoadjuvant nivolumab or nivolumab plus ipilimumab in operable non-small cell lung cancer: the phase 2 randomized NEOSTAR trial","volume":"27","author":"Cascone","year":"2021","journal-title":"Nat. Med."},{"issue":"4","key":"10.1016\/j.ejrad.2025.112267_b0190","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1093\/annonc\/mdz019","article-title":"Major pathologic response on biopsy (MPRbx) in patients with advanced melanoma treated with anti-PD-1: evidence for an early, on-therapy biomarker of response","volume":"30","author":"Stein","year":"2019","journal-title":"Ann. Oncol."},{"issue":"2","key":"10.1016\/j.ejrad.2025.112267_b0195","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.232908","article-title":"MRI Tumor Regression Response to Neoadjuvant Chemotherapy Alone without Radiation for Rectal Adenocarcinoma","volume":"312","author":"Shen","year":"2024","journal-title":"Radiology"},{"issue":"1","key":"10.1016\/j.ejrad.2025.112267_b0200","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1007\/s00330-019-06348-9","article-title":"The split scar sign as an indicator of sustained complete response after neoadjuvant therapy in rectal cancer","volume":"30","author":"Santiago","year":"2020","journal-title":"Eur. Radiol."},{"issue":"2","key":"10.1016\/j.ejrad.2025.112267_b0205","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1148\/radiol.212905","article-title":"Contrast-enhanced MRI for T Restaging of locally Advanced Rectal Cancer following Neoadjuvant Chemotherapy and Radiation Therapy","volume":"305","author":"Lu","year":"2022","journal-title":"Radiology"},{"issue":"9","key":"10.1016\/j.ejrad.2025.112267_b0210","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1001\/jamasurg.2023.2521","article-title":"Time Interval between the end of Neoadjuvant Therapy and Elective Resection of locally Advanced Rectal Cancer in the CRONOS Study","volume":"158","author":"Guzm\u00e1n","year":"2023","journal-title":"JAMA Surg."},{"key":"10.1016\/j.ejrad.2025.112267_b0215","doi-asserted-by":"crossref","unstructured":"N. Horvat, C. Carlos Tavares Rocha, B. Clemente Oliveira, I. Petkovska, M.J. Gollub, MRI of Rectal Cancer: Tumor Staging, Imaging Techniques, and Management, Radiographics 39(2) (2019) 367-387.","DOI":"10.1148\/rg.2019180114"},{"issue":"3","key":"10.1016\/j.ejrad.2025.112267_b0220","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1007\/s00261-020-02718-w","article-title":"Does microenema administration improve the quality of DWI sequences in rectal MRI?","volume":"46","author":"Jayaprakasam","year":"2021","journal-title":"Abdom Radiol (NY)"},{"key":"10.1016\/j.ejrad.2025.112267_b0225","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ejrad.2017.12.020","article-title":"Gas-induced susceptibility artefacts on diffusion-weighted MRI of the rectum at 1.5\u00a0T - effect of applying a micro-enema to improve image quality","volume":"99","author":"van Griethuysen","year":"2018","journal-title":"Eur. J. Radiol."},{"issue":"11","key":"10.1016\/j.ejrad.2025.112267_b0230","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.annonc.2024.07.729","article-title":"Organ preservation after neoadjuvant long-course chemoradiotherapy versus short-course radiotherapy","volume":"35","author":"Bercz","year":"2024","journal-title":"Ann. Oncol."},{"issue":"10","key":"10.1016\/j.ejrad.2025.112267_b0235","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1093\/bjs\/znab194","article-title":"Prevalence of nodal involvement in rectal cancer after chemoradiotherapy","volume":"108","author":"Haak","year":"2021","journal-title":"Br. J. Surg."},{"issue":"6","key":"10.1016\/j.ejrad.2025.112267_b0240","doi-asserted-by":"crossref","DOI":"10.1097\/SLA.0b013e3181f3f1b1","article-title":"Pathologic complete response of primary tumor following preoperative chemoradiotherapy for locally advanced rectal cancer: long-term outcomes and prognostic significance of pathologic nodal status (KROG 09-01)","volume":"252","author":"Yeo","year":"2010","journal-title":"Ann. Surg."},{"issue":"5","key":"10.1016\/j.ejrad.2025.112267_b0245","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1245\/s10434-012-2773-9","article-title":"What is the incidence of metastatic lymph node involvement after significant pathologic response of primary tumor following neoadjuvant treatment for locally advanced rectal cancer?","volume":"20","author":"Tranchart","year":"2013","journal-title":"Ann. Surg. Oncol."},{"issue":"12","key":"10.1016\/j.ejrad.2025.112267_b0250","doi-asserted-by":"crossref","first-page":"3440","DOI":"10.1007\/s00330-013-2956-1","article-title":"Locally advanced rectal cancer: is diffusion weighted MRI helpful for the identification of complete responders (ypT0N0) after neoadjuvant chemoradiation therapy?","volume":"23","author":"Sassen","year":"2013","journal-title":"Eur. Radiol."},{"issue":"4","key":"10.1016\/j.ejrad.2025.112267_b0255","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1007\/s00330-017-5026-2","article-title":"Magnetic resonance imaging for clinical management of rectal cancer: Updated recommendations from the 2016 European Society of Gastrointestinal and Abdominal Radiology (ESGAR) consensus meeting","volume":"28","author":"Beets-Tan","year":"2018","journal-title":"Eur. Radiol."},{"issue":"3","key":"10.1016\/j.ejrad.2025.112267_b0260","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1007\/s00330-018-5719-1","article-title":"Value of adding dynamic contrast-enhanced MRI visual assessment to conventional MRI and clinical assessment in the diagnosis of complete tumour response to chemoradiotherapy for rectal cancer","volume":"29","author":"Gollub","year":"2019","journal-title":"Eur. Radiol."},{"issue":"7","key":"10.1016\/j.ejrad.2025.112267_b0265","doi-asserted-by":"crossref","first-page":"4731","DOI":"10.1007\/s00330-020-07657-0","article-title":"Rectal cancer with complete endoscopic response after neoadjuvant therapy: what is the meaning of a positive MRI?","volume":"31","author":"Gollub","year":"2021","journal-title":"Eur. Radiol."},{"issue":"11","key":"10.1016\/j.ejrad.2025.112267_b0270","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-003261","article-title":"A machine learning model trained on dual-energy CT radiomics significantly improves immunotherapy response prediction for patients with stage IV melanoma","volume":"9","author":"Brendlin","year":"2021","journal-title":"J. Immunother. Cancer"},{"issue":"10","key":"10.1016\/j.ejrad.2025.112267_b0275","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-004867","article-title":"Radiomics to evaluate interlesion heterogeneity and to predict lesion response and patient outcomes using a validated signature of CD8 cells in advanced melanoma patients treated with anti-PD1 immunotherapy","volume":"10","author":"Sun","year":"2022","journal-title":"J. Immunother. Cancer"},{"issue":"10","key":"10.1016\/j.ejrad.2025.112267_b0280","doi-asserted-by":"crossref","first-page":"5392","DOI":"10.1007\/s00330-020-06847-0","article-title":"Radiomics-based prediction model for outcomes of PD-1\/PD-L1 immunotherapy in metastatic urothelial carcinoma","volume":"30","author":"Park","year":"2020","journal-title":"Eur. Radiol."}],"container-title":["European Journal of Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0720048X25003535?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0720048X25003535?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T17:43:25Z","timestamp":1753292605000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0720048X25003535"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":56,"alternative-id":["S0720048X25003535"],"URL":"https:\/\/doi.org\/10.1016\/j.ejrad.2025.112267","relation":{},"ISSN":["0720-048X"],"issn-type":[{"value":"0720-048X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Performance of conventional MRI and endoscopy in assessing complete tumor response following immunotherapy-based neoadjuvant therapy for rectal cancer","name":"articletitle","label":"Article Title"},{"value":"European Journal of Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejrad.2025.112267","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"112267"}}